Australia to include modern HTA/clinical evaluation methods in updated PBAC guidelines
This article was originally published in Scrip
Executive Summary
Australian health minister Sussan Ley has announced an in-depth review of the Pharmaceutical Benefits Advisory Committee (PBAC) guidelines, which are used by the pharmaceutical industry to prepare submissions to the PBAC for the listing of products on the Pharmaceutical Benefits Scheme (PBS).